Russ Hawkinson

Russ Hawkinson, listed as chief executive, appears in our data through filings on ARS Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 8 December 2020 and 2 May 2022, the trades on record add up to 3 filings.

On the market, this insider has only ever bought: 1 purchase, €3,467 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. Since January 2022: 1 purchase and no sales on the market.

Most recently, on 4 May 2022, the filings show a share grant in ARS Pharmaceuticals, Inc. The last insider purchase was made public on 24 February 2022, 1,698 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.